Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans

Results from the study supported the view that bretazenil may have a partial agonist pharmacologic profile. Scores on subjective effects scales considered important for abuse liability assessment suggest a lower abuse liability of bretazenil than diazepam and alprazolam.